

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of light stimulus involved in sensory perception (GO:0050962) | 9.05387552 |
| 2 | detection of light stimulus involved in visual perception (GO:0050908) | 9.05387552 |
| 3 | phototransduction (GO:0007602) | 9.04517835 |
| 4 | detection of light stimulus (GO:0009583) | 8.66574299 |
| 5 | phototransduction, visible light (GO:0007603) | 8.48025649 |
| 6 | GMP metabolic process (GO:0046037) | 8.42761973 |
| 7 | visual perception (GO:0007601) | 8.34155819 |
| 8 | detection of visible light (GO:0009584) | 8.28590690 |
| 9 | sensory perception of light stimulus (GO:0050953) | 8.24668685 |
| 10 | eye photoreceptor cell differentiation (GO:0001754) | 7.99918426 |
| 11 | photoreceptor cell differentiation (GO:0046530) | 7.99918426 |
| 12 | retina development in camera-type eye (GO:0060041) | 7.06617126 |
| 13 | protein-chromophore linkage (GO:0018298) | 6.56200496 |
| 14 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.28918008 |
| 15 | detection of external stimulus (GO:0009581) | 6.14671066 |
| 16 | detection of abiotic stimulus (GO:0009582) | 6.04056690 |
| 17 | cellular response to light stimulus (GO:0071482) | 5.96049639 |
| 18 | regulation of guanylate cyclase activity (GO:0031282) | 5.62889104 |
| 19 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.21770974 |
| 20 | regulation of clathrin-mediated endocytosis (GO:2000369) | 5.10127859 |
| 21 | nonmotile primary cilium assembly (GO:0035058) | 5.07036014 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95344654 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.80111670 |
| 24 | L-fucose catabolic process (GO:0042355) | 4.44072669 |
| 25 | fucose catabolic process (GO:0019317) | 4.44072669 |
| 26 | L-fucose metabolic process (GO:0042354) | 4.44072669 |
| 27 | regulation of cGMP metabolic process (GO:0030823) | 4.29276427 |
| 28 | retina layer formation (GO:0010842) | 4.24772202 |
| 29 | behavioral response to nicotine (GO:0035095) | 4.24572393 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.19076584 |
| 31 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.11817104 |
| 32 | regulation of cilium movement (GO:0003352) | 4.08999605 |
| 33 | neuron development (GO:0048666) | 4.06064500 |
| 34 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.04045501 |
| 35 | sensory perception (GO:0007600) | 4.02769419 |
| 36 | negative regulation of mast cell activation (GO:0033004) | 3.96727559 |
| 37 | response to pheromone (GO:0019236) | 3.93257237 |
| 38 | cellular response to radiation (GO:0071478) | 3.84910210 |
| 39 | estrogen biosynthetic process (GO:0006703) | 3.82464820 |
| 40 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.80544630 |
| 41 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.78255384 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 3.73426587 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 3.73426587 |
| 44 | tryptophan catabolic process (GO:0006569) | 3.73426587 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.63446190 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 3.62375040 |
| 47 | adaptation of signaling pathway (GO:0023058) | 3.58955922 |
| 48 | axoneme assembly (GO:0035082) | 3.53468975 |
| 49 | neuronal action potential propagation (GO:0019227) | 3.53326817 |
| 50 | regulation of cGMP biosynthetic process (GO:0030826) | 3.51830088 |
| 51 | protein polyglutamylation (GO:0018095) | 3.51530876 |
| 52 | protein localization to synapse (GO:0035418) | 3.51530196 |
| 53 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 3.48764271 |
| 54 | response to light stimulus (GO:0009416) | 3.38823303 |
| 55 | L-methionine salvage (GO:0071267) | 3.38164286 |
| 56 | L-methionine biosynthetic process (GO:0071265) | 3.38164286 |
| 57 | amino acid salvage (GO:0043102) | 3.38164286 |
| 58 | signal peptide processing (GO:0006465) | 3.37613983 |
| 59 | auditory receptor cell stereocilium organization (GO:0060088) | 3.34277950 |
| 60 | limb development (GO:0060173) | 3.33513826 |
| 61 | appendage development (GO:0048736) | 3.33513826 |
| 62 | positive regulation of cGMP metabolic process (GO:0030825) | 3.30462709 |
| 63 | synaptic vesicle maturation (GO:0016188) | 3.30167779 |
| 64 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.29465406 |
| 65 | positive regulation of vesicle fusion (GO:0031340) | 3.26259436 |
| 66 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.20844362 |
| 67 | regulation of glucokinase activity (GO:0033131) | 3.20305614 |
| 68 | regulation of hexokinase activity (GO:1903299) | 3.20305614 |
| 69 | sodium ion export (GO:0071436) | 3.19626569 |
| 70 | regulation of memory T cell differentiation (GO:0043380) | 3.19388554 |
| 71 | regulation of action potential (GO:0098900) | 3.13828574 |
| 72 | mannosylation (GO:0097502) | 3.08626039 |
| 73 | platelet dense granule organization (GO:0060155) | 3.06615169 |
| 74 | protein-cofactor linkage (GO:0018065) | 3.05554396 |
| 75 | methionine biosynthetic process (GO:0009086) | 3.04337661 |
| 76 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.02633221 |
| 77 | respiratory chain complex IV assembly (GO:0008535) | 2.99647401 |
| 78 | cellular potassium ion homeostasis (GO:0030007) | 2.99624625 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 2.97252144 |
| 80 | DNA deamination (GO:0045006) | 2.96890258 |
| 81 | righting reflex (GO:0060013) | 2.93224170 |
| 82 | cellular ketone body metabolic process (GO:0046950) | 2.92969990 |
| 83 | histone H3-K4 trimethylation (GO:0080182) | 2.92650213 |
| 84 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.92538188 |
| 85 | piRNA metabolic process (GO:0034587) | 2.91856811 |
| 86 | prenylation (GO:0097354) | 2.91276024 |
| 87 | protein prenylation (GO:0018342) | 2.91276024 |
| 88 | DNA double-strand break processing (GO:0000729) | 2.90845902 |
| 89 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.89356814 |
| 90 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.87792573 |
| 91 | tryptophan metabolic process (GO:0006568) | 2.87277608 |
| 92 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.87154418 |
| 93 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.83554561 |
| 94 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.83105860 |
| 95 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.82222807 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.81584253 |
| 97 | response to nitrosative stress (GO:0051409) | 2.80893684 |
| 98 | bile acid biosynthetic process (GO:0006699) | 2.80280087 |
| 99 | neural tube formation (GO:0001841) | 2.79615804 |
| 100 | male meiosis I (GO:0007141) | 2.78472900 |
| 101 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.77545680 |
| 102 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.77545680 |
| 103 | neuronal action potential (GO:0019228) | 2.77456156 |
| 104 | head development (GO:0060322) | 2.77036050 |
| 105 | imidazole-containing compound metabolic process (GO:0052803) | 2.76694984 |
| 106 | cytochrome complex assembly (GO:0017004) | 2.76218144 |
| 107 | glycine transport (GO:0015816) | 2.74860005 |
| 108 | adenosine metabolic process (GO:0046085) | 2.74601958 |
| 109 | membrane hyperpolarization (GO:0060081) | 2.73571673 |
| 110 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.73418243 |
| 111 | cilium morphogenesis (GO:0060271) | 2.73293695 |
| 112 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.73041930 |
| 113 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.71533047 |
| 114 | amine catabolic process (GO:0009310) | 2.71444053 |
| 115 | cellular biogenic amine catabolic process (GO:0042402) | 2.71444053 |
| 116 | positive regulation of neurotransmitter transport (GO:0051590) | 2.71056432 |
| 117 | negative regulation of interleukin-1 production (GO:0032692) | 2.69945408 |
| 118 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.69896519 |
| 119 | potassium ion homeostasis (GO:0055075) | 2.69476459 |
| 120 | inner ear receptor stereocilium organization (GO:0060122) | 2.65277629 |
| 121 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.65177238 |
| 122 | protein K11-linked deubiquitination (GO:0035871) | 2.63397455 |
| 123 | retina homeostasis (GO:0001895) | 2.62776355 |
| 124 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.61874515 |
| 125 | positive regulation of glycolytic process (GO:0045821) | 2.59313719 |
| 126 | ketone body metabolic process (GO:1902224) | 2.59157297 |
| 127 | protein complex biogenesis (GO:0070271) | 2.54924945 |
| 128 | nucleotide transmembrane transport (GO:1901679) | 2.54605763 |
| 129 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.54464275 |
| 130 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.52237978 |
| 131 | glycerophospholipid catabolic process (GO:0046475) | 2.52165573 |
| 132 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.51639895 |
| 133 | regulation of vesicle fusion (GO:0031338) | 2.51187758 |
| 134 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.50289357 |
| 135 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.49994229 |
| 136 | rRNA catabolic process (GO:0016075) | 2.49871052 |
| 137 | fatty acid elongation (GO:0030497) | 2.49527966 |
| 138 | lipoprotein transport (GO:0042953) | 2.49348476 |
| 139 | methionine metabolic process (GO:0006555) | 2.48842001 |
| 140 | synaptic vesicle exocytosis (GO:0016079) | 2.48174682 |
| 141 | chemosensory behavior (GO:0007635) | 2.47841523 |
| 142 | sterol catabolic process (GO:0016127) | 2.45773579 |
| 143 | cholesterol catabolic process (GO:0006707) | 2.45773579 |
| 144 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.45216397 |
| 145 | nephron tubule morphogenesis (GO:0072078) | 2.44929263 |
| 146 | nephron epithelium morphogenesis (GO:0072088) | 2.44929263 |
| 147 | oxidative demethylation (GO:0070989) | 2.44492187 |
| 148 | indole-containing compound metabolic process (GO:0042430) | 2.44117410 |
| 149 | behavioral response to ethanol (GO:0048149) | 2.43660029 |
| 150 | benzene-containing compound metabolic process (GO:0042537) | 2.43595790 |
| 151 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.43391208 |
| 152 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.42663200 |
| 153 | multicellular organism reproduction (GO:0032504) | 2.42416412 |
| 154 | gamma-aminobutyric acid transport (GO:0015812) | 2.41442044 |
| 155 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.40294592 |
| 156 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.40180065 |
| 157 | GPI anchor metabolic process (GO:0006505) | 2.39426983 |
| 158 | replication fork processing (GO:0031297) | 2.39286632 |
| 159 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.39244419 |
| 160 | cilium organization (GO:0044782) | 2.38551402 |
| 161 | retinoid metabolic process (GO:0001523) | 2.38400365 |
| 162 | startle response (GO:0001964) | 2.35879851 |
| 163 | protein localization to cilium (GO:0061512) | 2.35240381 |
| 164 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.32528257 |
| 165 | response to radiation (GO:0009314) | 2.30344599 |
| 166 | apical protein localization (GO:0045176) | 2.29832998 |
| 167 | phospholipid translocation (GO:0045332) | 2.29256167 |
| 168 | lipid translocation (GO:0034204) | 2.29256167 |
| 169 | lactate metabolic process (GO:0006089) | 2.25515708 |
| 170 | glutamate secretion (GO:0014047) | 2.25317613 |
| 171 | regulation of synaptic vesicle transport (GO:1902803) | 2.24514366 |
| 172 | diterpenoid metabolic process (GO:0016101) | 2.23608320 |
| 173 | potassium ion import (GO:0010107) | 2.22942859 |
| 174 | neuron remodeling (GO:0016322) | 2.22267780 |
| 175 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.21932142 |
| 176 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.21700444 |
| 177 | calcium ion import (GO:0070509) | 2.19419625 |
| 178 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 13.9003157 |
| 179 | rhodopsin mediated signaling pathway (GO:0016056) | 13.4769268 |
| 180 | photoreceptor cell development (GO:0042461) | 12.7042026 |
| 181 | retinal cone cell development (GO:0046549) | 12.4623589 |
| 182 | eye photoreceptor cell development (GO:0042462) | 12.1363532 |
| 183 | photoreceptor cell maintenance (GO:0045494) | 12.1253537 |
| 184 | retinal rod cell development (GO:0046548) | 11.7491544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.56198076 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.03747001 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.89598671 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.87991123 |
| 5 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.71079771 |
| 6 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 2.58204223 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.21241149 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21188873 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.20287464 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09972073 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00578010 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.98697865 |
| 13 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.97526974 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.97028592 |
| 15 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94407346 |
| 16 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93329429 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92177370 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91930448 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.91883709 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86061940 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.82978548 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.82978548 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.82700530 |
| 24 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.80747301 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.80467573 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.79832709 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.77798590 |
| 28 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.75365395 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.74335981 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.72231628 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.71864040 |
| 32 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.70860458 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70766341 |
| 34 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69250496 |
| 35 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.69157546 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.69001786 |
| 37 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.67175491 |
| 38 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65890223 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64995826 |
| 40 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.64501097 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64452396 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.62335681 |
| 43 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.61537426 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58320420 |
| 45 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58247465 |
| 46 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54068302 |
| 47 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.51924278 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51724222 |
| 49 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.51561867 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49814844 |
| 51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.48543177 |
| 52 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.47436279 |
| 53 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.44620058 |
| 54 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.44235802 |
| 55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43142039 |
| 56 | TBL1_22424771_ChIP-Seq_293T_Human | 1.43010104 |
| 57 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.42868317 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.42777833 |
| 59 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.42043626 |
| 60 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.42043626 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.41050813 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.40827350 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.40342887 |
| 64 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.40089362 |
| 65 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.39749158 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.38809853 |
| 67 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.38574922 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36611179 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.35401903 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.35281221 |
| 71 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35279476 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.35099863 |
| 73 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.34475927 |
| 74 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33614688 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32968913 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32722829 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31771346 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.30571318 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29680051 |
| 80 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29591499 |
| 81 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29591499 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28838273 |
| 83 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.28809384 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28709721 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28709721 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27454970 |
| 87 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.27422767 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25754240 |
| 89 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.25171198 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25149803 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24892185 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24495670 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.24413810 |
| 94 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24308920 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23739459 |
| 96 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23646175 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.23538290 |
| 98 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23329748 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23125417 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23085450 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.23069702 |
| 102 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22454108 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.22290197 |
| 104 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.22162770 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22113089 |
| 106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19793827 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18375698 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18368641 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18201345 |
| 110 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.17438459 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17191164 |
| 112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.16285745 |
| 113 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15901992 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15179518 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14793597 |
| 116 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.14249988 |
| 117 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13158349 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13100745 |
| 119 | NCOR_22424771_ChIP-Seq_293T_Human | 1.13027591 |
| 120 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.11865857 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10305992 |
| 122 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10156534 |
| 123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08014141 |
| 124 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07846698 |
| 125 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07564394 |
| 126 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07522831 |
| 127 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.07469423 |
| 128 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.06882571 |
| 129 | AR_20517297_ChIP-Seq_VCAP_Human | 1.06823203 |
| 130 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06329798 |
| 131 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05693140 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.05189009 |
| 133 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04918451 |
| 134 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04725211 |
| 135 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03485631 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.03023842 |
| 137 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.02841297 |
| 138 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02075978 |
| 139 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01664606 |
| 140 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.01521261 |
| 141 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.01506243 |
| 142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01058450 |
| 143 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00283545 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00028679 |
| 145 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98746289 |
| 146 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98242184 |
| 147 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97765043 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.96804898 |
| 149 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96576296 |
| 150 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96170651 |
| 151 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95303768 |
| 152 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94802027 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94802027 |
| 154 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94528143 |
| 155 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94243458 |
| 156 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.94107760 |
| 157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92546535 |
| 158 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91409539 |
| 159 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90919131 |
| 160 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90557865 |
| 161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90189542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 9.21577148 |
| 2 | MP0003011_delayed_dark_adaptation | 8.67957306 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 7.00447081 |
| 4 | MP0005253_abnormal_eye_physiology | 6.40290706 |
| 5 | MP0005195_abnormal_posterior_eye | 4.10882626 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.49046264 |
| 7 | MP0005391_vision/eye_phenotype | 3.26399636 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.23043863 |
| 9 | MP0002653_abnormal_ependyma_morphology | 3.22239312 |
| 10 | MP0003195_calcinosis | 2.97233790 |
| 11 | MP0002229_neurodegeneration | 2.71551159 |
| 12 | MP0002638_abnormal_pupillary_reflex | 2.67577439 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.63457638 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.33906205 |
| 15 | MP0002090_abnormal_vision | 2.28746194 |
| 16 | MP0002736_abnormal_nociception_after | 2.25735022 |
| 17 | MP0001502_abnormal_circadian_rhythm | 2.24844803 |
| 18 | MP0002752_abnormal_somatic_nervous | 2.19895082 |
| 19 | MP0005645_abnormal_hypothalamus_physiol | 2.18653897 |
| 20 | MP0004147_increased_porphyrin_level | 2.13545594 |
| 21 | MP0008872_abnormal_physiological_respon | 2.09028298 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.90061396 |
| 23 | MP0000372_irregular_coat_pigmentation | 1.83220899 |
| 24 | MP0002254_reproductive_system_inflammat | 1.81796376 |
| 25 | MP0001873_stomach_inflammation | 1.75941275 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.65649450 |
| 27 | MP0004885_abnormal_endolymph | 1.62447625 |
| 28 | MP0002882_abnormal_neuron_morphology | 1.61945775 |
| 29 | MP0002163_abnormal_gland_morphology | 1.55943008 |
| 30 | MP0005499_abnormal_olfactory_system | 1.47945747 |
| 31 | MP0005394_taste/olfaction_phenotype | 1.47945747 |
| 32 | MP0005084_abnormal_gallbladder_morpholo | 1.44835943 |
| 33 | MP0008789_abnormal_olfactory_epithelium | 1.43819857 |
| 34 | MP0003252_abnormal_bile_duct | 1.33887155 |
| 35 | MP0005410_abnormal_fertilization | 1.32801460 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.29785858 |
| 37 | MP0005671_abnormal_response_to | 1.25896418 |
| 38 | MP0001764_abnormal_homeostasis | 1.24656702 |
| 39 | MP0004270_analgesia | 1.22757004 |
| 40 | MP0001984_abnormal_olfaction | 1.21367531 |
| 41 | MP0003880_abnormal_central_pattern | 1.20453800 |
| 42 | MP0005248_abnormal_Harderian_gland | 1.20448656 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.19198763 |
| 44 | MP0000427_abnormal_hair_cycle | 1.18821177 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.17853903 |
| 46 | MP0003718_maternal_effect | 1.16827840 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.14491217 |
| 48 | MP0008058_abnormal_DNA_repair | 1.12864534 |
| 49 | MP0001486_abnormal_startle_reflex | 1.12481513 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.12148134 |
| 51 | MP0002928_abnormal_bile_duct | 1.11263448 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.11091446 |
| 53 | MP0004043_abnormal_pH_regulation | 1.10643741 |
| 54 | MP0002160_abnormal_reproductive_system | 1.06229504 |
| 55 | MP0004133_heterotaxia | 1.06044638 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.03803926 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.02215558 |
| 58 | MP0002102_abnormal_ear_morphology | 1.01953391 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.01675549 |
| 60 | MP0002938_white_spotting | 1.01540407 |
| 61 | MP0005365_abnormal_bile_salt | 0.98980450 |
| 62 | MP0001346_abnormal_lacrimal_gland | 0.98901199 |
| 63 | MP0005389_reproductive_system_phenotype | 0.97699198 |
| 64 | MP0005174_abnormal_tail_pigmentation | 0.97142451 |
| 65 | MP0001986_abnormal_taste_sensitivity | 0.97070438 |
| 66 | MP0003122_maternal_imprinting | 0.96566797 |
| 67 | MP0005197_abnormal_uvea_morphology | 0.96143638 |
| 68 | MP0003283_abnormal_digestive_organ | 0.95473396 |
| 69 | MP0005187_abnormal_penis_morphology | 0.93831866 |
| 70 | MP0004859_abnormal_synaptic_plasticity | 0.93428831 |
| 71 | MP0001529_abnormal_vocalization | 0.93183358 |
| 72 | MP0006054_spinal_hemorrhage | 0.92223138 |
| 73 | MP0003121_genomic_imprinting | 0.89384544 |
| 74 | MP0001919_abnormal_reproductive_system | 0.89103314 |
| 75 | MP0000383_abnormal_hair_follicle | 0.88400947 |
| 76 | MP0001286_abnormal_eye_development | 0.86867767 |
| 77 | MP0002272_abnormal_nervous_system | 0.86437376 |
| 78 | MP0003634_abnormal_glial_cell | 0.86071530 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 0.85607387 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 0.85422733 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 0.84344418 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83751185 |
| 83 | MP0000778_abnormal_nervous_system | 0.80783939 |
| 84 | MP0005395_other_phenotype | 0.80674236 |
| 85 | MP0005647_abnormal_sex_gland | 0.80481993 |
| 86 | MP0002697_abnormal_eye_size | 0.80109802 |
| 87 | MP0003045_fibrosis | 0.79321914 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.79288097 |
| 89 | MP0002693_abnormal_pancreas_physiology | 0.78569665 |
| 90 | MP0002734_abnormal_mechanical_nocicepti | 0.77932925 |
| 91 | MP0001119_abnormal_female_reproductive | 0.77854881 |
| 92 | MP0005448_abnormal_energy_balance | 0.77568995 |
| 93 | MP0003119_abnormal_digestive_system | 0.76345234 |
| 94 | MP0002064_seizures | 0.76245031 |
| 95 | MP0004742_abnormal_vestibular_system | 0.74747407 |
| 96 | MP0004233_abnormal_muscle_weight | 0.74471188 |
| 97 | MP0002234_abnormal_pharynx_morphology | 0.74339817 |
| 98 | MP0001944_abnormal_pancreas_morphology | 0.73373509 |
| 99 | MP0009046_muscle_twitch | 0.73321794 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.72655826 |
| 101 | MP0002168_other_aberrant_phenotype | 0.72415466 |
| 102 | MP0001963_abnormal_hearing_physiology | 0.69910999 |
| 103 | MP0004019_abnormal_vitamin_homeostasis | 0.65855033 |
| 104 | MP0002063_abnormal_learning/memory/cond | 0.64426388 |
| 105 | MP0002067_abnormal_sensory_capabilities | 0.63796505 |
| 106 | MP0002184_abnormal_innervation | 0.62533982 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.59060949 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.57874728 |
| 109 | MP0009745_abnormal_behavioral_response | 0.57283179 |
| 110 | MP0003787_abnormal_imprinting | 0.55849182 |
| 111 | MP0002572_abnormal_emotion/affect_behav | 0.55589351 |
| 112 | MP0001293_anophthalmia | 0.54845949 |
| 113 | MP0008004_abnormal_stomach_pH | 0.54653134 |
| 114 | MP0002152_abnormal_brain_morphology | 0.52449735 |
| 115 | MP0004924_abnormal_behavior | 0.49852854 |
| 116 | MP0005386_behavior/neurological_phenoty | 0.49852854 |
| 117 | MP0000026_abnormal_inner_ear | 0.47735718 |
| 118 | MP0000465_gastrointestinal_hemorrhage | 0.45294646 |
| 119 | MP0005646_abnormal_pituitary_gland | 0.45111720 |
| 120 | MP0001968_abnormal_touch/_nociception | 0.45007195 |
| 121 | MP0003861_abnormal_nervous_system | 0.44226118 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.43794898 |
| 123 | MP0003698_abnormal_male_reproductive | 0.43446197 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.43372539 |
| 125 | MP0003632_abnormal_nervous_system | 0.42147617 |
| 126 | MP0000955_abnormal_spinal_cord | 0.42041994 |
| 127 | MP0005193_abnormal_anterior_eye | 0.39956988 |
| 128 | MP0002557_abnormal_social/conspecific_i | 0.39108260 |
| 129 | MP0002066_abnormal_motor_capabilities/c | 0.38949803 |
| 130 | MP0004215_abnormal_myocardial_fiber | 0.38004363 |
| 131 | MP0008569_lethality_at_weaning | 0.35410613 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.34194611 |
| 133 | MP0000579_abnormal_nail_morphology | 0.33538015 |
| 134 | MP0003646_muscle_fatigue | 0.33099057 |
| 135 | MP0004811_abnormal_neuron_physiology | 0.32873010 |
| 136 | MP0001915_intracranial_hemorrhage | 0.32735667 |
| 137 | MP0003633_abnormal_nervous_system | 0.32328662 |
| 138 | MP0008961_abnormal_basal_metabolism | 0.31444642 |
| 139 | MP0004085_abnormal_heartbeat | 0.30400330 |
| 140 | MP0003631_nervous_system_phenotype | 0.30229400 |
| 141 | MP0009780_abnormal_chondrocyte_physiolo | 0.29416935 |
| 142 | MP0002092_abnormal_eye_morphology | 0.29291465 |
| 143 | MP0001440_abnormal_grooming_behavior | 0.28151943 |
| 144 | MP0001501_abnormal_sleep_pattern | 0.27577391 |
| 145 | MP0004142_abnormal_muscle_tone | 0.27564659 |
| 146 | MP0001929_abnormal_gametogenesis | 0.25657157 |
| 147 | MP0001970_abnormal_pain_threshold | 0.25208051 |
| 148 | MP0005257_abnormal_intraocular_pressure | 0.24010940 |
| 149 | MP0002161_abnormal_fertility/fecundity | 0.22877321 |
| 150 | MP0006276_abnormal_autonomic_nervous | 0.22294733 |
| 151 | MP0001177_atelectasis | 0.20846603 |
| 152 | MP0002069_abnormal_eating/drinking_beha | 0.20626091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pendular nystagmus (HP:0012043) | 9.63004799 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 9.47354017 |
| 3 | Chorioretinal atrophy (HP:0000533) | 9.21591471 |
| 4 | Abolished electroretinogram (ERG) (HP:0000550) | 8.83421570 |
| 5 | Pigmentary retinal degeneration (HP:0001146) | 8.33559805 |
| 6 | Central scotoma (HP:0000603) | 8.13193665 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 7.03384669 |
| 8 | Dyschromatopsia (HP:0007641) | 6.93284580 |
| 9 | Decreased central vision (HP:0007663) | 6.90855092 |
| 10 | Scotoma (HP:0000575) | 6.85985289 |
| 11 | Severe visual impairment (HP:0001141) | 6.73937562 |
| 12 | Posterior subcapsular cataract (HP:0007787) | 6.31895075 |
| 13 | Attenuation of retinal blood vessels (HP:0007843) | 6.24044710 |
| 14 | Keratoconus (HP:0000563) | 5.77586556 |
| 15 | Increased corneal curvature (HP:0100692) | 5.77586556 |
| 16 | Macular degeneration (HP:0000608) | 5.55489140 |
| 17 | Cone-rod dystrophy (HP:0000548) | 5.42157538 |
| 18 | Vitreoretinal degeneration (HP:0000655) | 5.39119894 |
| 19 | Type II diabetes mellitus (HP:0005978) | 5.22571417 |
| 20 | Photophobia (HP:0000613) | 5.04815291 |
| 21 | Chronic hepatic failure (HP:0100626) | 4.64537664 |
| 22 | Constricted visual fields (HP:0001133) | 4.57180028 |
| 23 | Subcapsular cataract (HP:0000523) | 3.86853077 |
| 24 | Retinitis pigmentosa (HP:0000510) | 3.71701297 |
| 25 | Renal cortical cysts (HP:0000803) | 3.45251264 |
| 26 | Choroideremia (HP:0001139) | 3.26611553 |
| 27 | Progressive visual loss (HP:0000529) | 3.20602929 |
| 28 | Methylmalonic acidemia (HP:0002912) | 3.02934019 |
| 29 | Abnormality of the renal cortex (HP:0011035) | 3.00496330 |
| 30 | Stomatitis (HP:0010280) | 2.95245768 |
| 31 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.85602335 |
| 32 | Abnormality of alanine metabolism (HP:0010916) | 2.85379010 |
| 33 | Hyperalaninemia (HP:0003348) | 2.85379010 |
| 34 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.85379010 |
| 35 | Gaze-evoked nystagmus (HP:0000640) | 2.68987496 |
| 36 | Congenital sensorineural hearing impairment (HP:0008527) | 2.56880571 |
| 37 | Atonic seizures (HP:0010819) | 2.54812726 |
| 38 | Methylmalonic aciduria (HP:0012120) | 2.50107944 |
| 39 | Type II lissencephaly (HP:0007260) | 2.42893859 |
| 40 | Hyperventilation (HP:0002883) | 2.39243256 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39056759 |
| 42 | Progressive macrocephaly (HP:0004481) | 2.36573227 |
| 43 | Wide nasal bridge (HP:0000431) | 2.34640425 |
| 44 | Acute encephalopathy (HP:0006846) | 2.33919901 |
| 45 | Dialeptic seizures (HP:0011146) | 2.32352817 |
| 46 | Pancreatic fibrosis (HP:0100732) | 2.29950377 |
| 47 | True hermaphroditism (HP:0010459) | 2.29788907 |
| 48 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.28721508 |
| 49 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.28721508 |
| 50 | Abnormal protein glycosylation (HP:0012346) | 2.28721508 |
| 51 | Abnormal glycosylation (HP:0012345) | 2.28721508 |
| 52 | Fair hair (HP:0002286) | 2.25788801 |
| 53 | Acute necrotizing encephalopathy (HP:0006965) | 2.24788811 |
| 54 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.22639487 |
| 55 | Increased CSF lactate (HP:0002490) | 2.21846604 |
| 56 | Focal seizures (HP:0007359) | 2.21628501 |
| 57 | Absence seizures (HP:0002121) | 2.17749036 |
| 58 | Hemiparesis (HP:0001269) | 2.16999919 |
| 59 | Progressive inability to walk (HP:0002505) | 2.15310570 |
| 60 | Polar cataract (HP:0010696) | 2.14955499 |
| 61 | Abnormality of vitamin B metabolism (HP:0004340) | 2.13400004 |
| 62 | Gait imbalance (HP:0002141) | 2.12993251 |
| 63 | Congenital primary aphakia (HP:0007707) | 2.09355337 |
| 64 | Hepatic necrosis (HP:0002605) | 2.05885745 |
| 65 | Mitochondrial inheritance (HP:0001427) | 2.04765890 |
| 66 | Abnormality of the labia minora (HP:0012880) | 2.03056958 |
| 67 | Retinal atrophy (HP:0001105) | 2.02551193 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01355818 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 11.7417538 |
| 70 | Congenital stationary night blindness (HP:0007642) | 10.6227890 |
| 71 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.5314706 |
| 72 | Hepatocellular necrosis (HP:0001404) | 1.97267938 |
| 73 | Optic disc pallor (HP:0000543) | 1.96099457 |
| 74 | Hypoalbuminemia (HP:0003073) | 1.93977098 |
| 75 | Abnormal albumin level (HP:0012116) | 1.93977098 |
| 76 | Abnormality of methionine metabolism (HP:0010901) | 1.93288958 |
| 77 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.90933027 |
| 78 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.90933027 |
| 79 | Stomach cancer (HP:0012126) | 1.89505106 |
| 80 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.88436203 |
| 81 | Nephrogenic diabetes insipidus (HP:0009806) | 1.88337099 |
| 82 | Broad-based gait (HP:0002136) | 1.88205269 |
| 83 | Sclerocornea (HP:0000647) | 1.86143655 |
| 84 | Large for gestational age (HP:0001520) | 1.85979237 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 1.85189122 |
| 86 | Pancreatic cysts (HP:0001737) | 1.85149887 |
| 87 | Inability to walk (HP:0002540) | 1.84261060 |
| 88 | Type I transferrin isoform profile (HP:0003642) | 1.83692470 |
| 89 | Abnormal pancreas size (HP:0012094) | 1.83632516 |
| 90 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83527711 |
| 91 | Abnormal biliary tract physiology (HP:0012439) | 1.83235342 |
| 92 | Bile duct proliferation (HP:0001408) | 1.83235342 |
| 93 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.83193312 |
| 94 | Cerebellar dysplasia (HP:0007033) | 1.82762422 |
| 95 | Cystic liver disease (HP:0006706) | 1.81589622 |
| 96 | Abnormality of the pons (HP:0007361) | 1.80822901 |
| 97 | Intrahepatic cholestasis (HP:0001406) | 1.80114825 |
| 98 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.79031023 |
| 99 | Abnormality of homocysteine metabolism (HP:0010919) | 1.78180420 |
| 100 | Homocystinuria (HP:0002156) | 1.78180420 |
| 101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.76883729 |
| 102 | Absent/shortened dynein arms (HP:0200106) | 1.76883729 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 1.76829792 |
| 104 | Hypothermia (HP:0002045) | 1.74098961 |
| 105 | Severe Myopia (HP:0011003) | 1.67127183 |
| 106 | Poor coordination (HP:0002370) | 1.64431402 |
| 107 | Vaginal atresia (HP:0000148) | 1.52812567 |
| 108 | Optic atrophy (HP:0000648) | 1.52756047 |
| 109 | Genital tract atresia (HP:0001827) | 1.51080208 |
| 110 | Horizontal nystagmus (HP:0000666) | 1.48173781 |
| 111 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.39602181 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 1.35047054 |
| 113 | Septo-optic dysplasia (HP:0100842) | 1.30224107 |
| 114 | Epileptic encephalopathy (HP:0200134) | 1.30174190 |
| 115 | Abnormality of the fovea (HP:0000493) | 1.29662924 |
| 116 | Hypoplasia of the fovea (HP:0007750) | 1.25398566 |
| 117 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.25398566 |
| 118 | Chorioretinal coloboma (HP:0000567) | 1.22657492 |
| 119 | Anencephaly (HP:0002323) | 1.20186915 |
| 120 | Anophthalmia (HP:0000528) | 1.16372645 |
| 121 | Furrowed tongue (HP:0000221) | 1.15525850 |
| 122 | Dysdiadochokinesis (HP:0002075) | 1.14135967 |
| 123 | Abnormality of midbrain morphology (HP:0002418) | 1.13098975 |
| 124 | Molar tooth sign on MRI (HP:0002419) | 1.13098975 |
| 125 | Congenital hepatic fibrosis (HP:0002612) | 1.07605785 |
| 126 | Recurrent sinusitis (HP:0011108) | 1.06758141 |
| 127 | Hypermetropia (HP:0000540) | 1.06241071 |
| 128 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.06154048 |
| 129 | Febrile seizures (HP:0002373) | 1.06028586 |
| 130 | Abnormality of abdominal situs (HP:0011620) | 1.03526565 |
| 131 | Abdominal situs inversus (HP:0003363) | 1.03526565 |
| 132 | Astigmatism (HP:0000483) | 1.02520738 |
| 133 | Postaxial foot polydactyly (HP:0001830) | 0.99493380 |
| 134 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.98493485 |
| 135 | Visual hallucinations (HP:0002367) | 0.97386588 |
| 136 | Genetic anticipation (HP:0003743) | 0.95097703 |
| 137 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.94545618 |
| 138 | Progressive cerebellar ataxia (HP:0002073) | 0.94091861 |
| 139 | Oligodactyly (hands) (HP:0001180) | 0.91410160 |
| 140 | Specific learning disability (HP:0001328) | 0.90556053 |
| 141 | Retinal detachment (HP:0000541) | 0.89616419 |
| 142 | Abnormality of the fingertips (HP:0001211) | 0.89118283 |
| 143 | Abnormality of the lower motor neuron (HP:0002366) | 0.88839083 |
| 144 | Nephronophthisis (HP:0000090) | 0.88260191 |
| 145 | Preaxial hand polydactyly (HP:0001177) | 0.86533274 |
| 146 | Postaxial hand polydactyly (HP:0001162) | 0.86284803 |
| 147 | Lip pit (HP:0100267) | 0.84705837 |
| 148 | Abnormality of the parathyroid morphology (HP:0011766) | 0.82691196 |
| 149 | Male pseudohermaphroditism (HP:0000037) | 0.82266099 |
| 150 | Asthma (HP:0002099) | 0.81770326 |
| 151 | Left ventricular hypertrophy (HP:0001712) | 0.80504797 |
| 152 | Broad foot (HP:0001769) | 0.79364325 |
| 153 | Supranuclear gaze palsy (HP:0000605) | 0.75474776 |
| 154 | Decreased testicular size (HP:0008734) | 0.74877584 |
| 155 | Abnormality of the renal medulla (HP:0100957) | 0.71585796 |
| 156 | Insomnia (HP:0100785) | 0.71529750 |
| 157 | Absent septum pellucidum (HP:0001331) | 0.69443093 |
| 158 | Abnormality of dental color (HP:0011073) | 0.68773850 |
| 159 | Aqueductal stenosis (HP:0002410) | 0.68691331 |
| 160 | Holoprosencephaly (HP:0001360) | 0.68666314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 7.21111519 |
| 2 | FRK | 6.40134247 |
| 3 | IRAK2 | 3.89686485 |
| 4 | MAP3K10 | 3.32727832 |
| 5 | ADRBK2 | 3.14419504 |
| 6 | MAP4K2 | 3.03105788 |
| 7 | WNK3 | 2.78891617 |
| 8 | PBK | 2.69913317 |
| 9 | PINK1 | 2.54805309 |
| 10 | PDK2 | 2.25973648 |
| 11 | TRIM28 | 2.21228239 |
| 12 | LATS1 | 2.06535438 |
| 13 | SIK2 | 2.04341831 |
| 14 | CAMK1G | 1.96269252 |
| 15 | CDK12 | 1.96005577 |
| 16 | OXSR1 | 1.90976872 |
| 17 | BRD4 | 1.89439663 |
| 18 | MAP3K4 | 1.86225157 |
| 19 | WNK4 | 1.85054243 |
| 20 | PNCK | 1.84373710 |
| 21 | SGK223 | 1.82075938 |
| 22 | SGK494 | 1.82075938 |
| 23 | ZAK | 1.80629499 |
| 24 | PAK6 | 1.78466236 |
| 25 | EIF2AK3 | 1.74171644 |
| 26 | ERBB2 | 1.68304969 |
| 27 | BMPR1B | 1.67372566 |
| 28 | LMTK2 | 1.64746440 |
| 29 | FER | 1.64603080 |
| 30 | CDK3 | 1.57353869 |
| 31 | TAOK3 | 1.53633105 |
| 32 | ICK | 1.52403136 |
| 33 | STK39 | 1.51861013 |
| 34 | CAMKK2 | 1.45714531 |
| 35 | ACVR1B | 1.45121426 |
| 36 | MAP3K6 | 1.38200155 |
| 37 | CAMK1D | 1.35095160 |
| 38 | TXK | 1.34560005 |
| 39 | PRPF4B | 1.30214630 |
| 40 | STK38 | 1.30179142 |
| 41 | MATK | 1.29603701 |
| 42 | DAPK2 | 1.29587597 |
| 43 | PRKD3 | 1.28791526 |
| 44 | MAP3K9 | 1.28128922 |
| 45 | HIPK2 | 1.26785957 |
| 46 | MAP2K7 | 1.25498331 |
| 47 | NLK | 1.21500279 |
| 48 | TNIK | 1.21466093 |
| 49 | INSRR | 1.20069476 |
| 50 | CDK9 | 1.15618437 |
| 51 | MARK1 | 1.14303260 |
| 52 | ADRBK1 | 1.13269955 |
| 53 | NTRK2 | 1.12660042 |
| 54 | DYRK1A | 1.11201262 |
| 55 | DYRK2 | 1.10824861 |
| 56 | MAPK12 | 1.08219296 |
| 57 | MAPK7 | 1.05018477 |
| 58 | CSNK1D | 1.00877794 |
| 59 | PRKCE | 0.99660605 |
| 60 | PRKCH | 0.99036256 |
| 61 | KSR1 | 0.96265533 |
| 62 | WNK1 | 0.94817110 |
| 63 | VRK2 | 0.92466128 |
| 64 | SGK2 | 0.91350145 |
| 65 | IKBKB | 0.89964782 |
| 66 | MKNK2 | 0.89882388 |
| 67 | PIK3CG | 0.87849197 |
| 68 | PRKCQ | 0.87182049 |
| 69 | PLK2 | 0.86093638 |
| 70 | PRKAA1 | 0.85924032 |
| 71 | PRKCG | 0.84043066 |
| 72 | VRK1 | 0.83222582 |
| 73 | PRKD2 | 0.83163568 |
| 74 | IRAK1 | 0.82954261 |
| 75 | BRSK2 | 0.80823202 |
| 76 | NUAK1 | 0.78708446 |
| 77 | NEK2 | 0.78588843 |
| 78 | LIMK1 | 0.77966239 |
| 79 | PIK3CA | 0.76409342 |
| 80 | AKT3 | 0.75937166 |
| 81 | MST4 | 0.74809912 |
| 82 | MAP2K4 | 0.74721002 |
| 83 | SIK3 | 0.73924974 |
| 84 | SIK1 | 0.72822736 |
| 85 | PRKAA2 | 0.72206308 |
| 86 | DYRK3 | 0.70809976 |
| 87 | STK16 | 0.70563320 |
| 88 | CDK19 | 0.69778901 |
| 89 | SGK1 | 0.69088418 |
| 90 | CSNK1G1 | 0.68648028 |
| 91 | MAPK13 | 0.68317623 |
| 92 | GSK3B | 0.68127047 |
| 93 | TLK1 | 0.68079889 |
| 94 | NTRK3 | 0.67148842 |
| 95 | MAPK10 | 0.65659530 |
| 96 | MARK2 | 0.64194736 |
| 97 | GRK5 | 0.64189993 |
| 98 | MAPK14 | 0.64112876 |
| 99 | CAMK2A | 0.63895746 |
| 100 | SGK3 | 0.63539300 |
| 101 | PRKCB | 0.63436078 |
| 102 | CASK | 0.62723855 |
| 103 | PHKG2 | 0.62648091 |
| 104 | PHKG1 | 0.62648091 |
| 105 | KSR2 | 0.61897289 |
| 106 | PRKCZ | 0.61120684 |
| 107 | RPS6KA3 | 0.60882348 |
| 108 | TIE1 | 0.60242540 |
| 109 | BCR | 0.59666670 |
| 110 | CDK1 | 0.58308966 |
| 111 | CDK5 | 0.58263914 |
| 112 | MAP3K13 | 0.58062399 |
| 113 | DYRK1B | 0.57047704 |
| 114 | MAPK9 | 0.56812741 |
| 115 | CSNK1G3 | 0.55959397 |
| 116 | TEC | 0.54992834 |
| 117 | TNK2 | 0.54616802 |
| 118 | PLK3 | 0.53453220 |
| 119 | CDK8 | 0.53268857 |
| 120 | CAMK1 | 0.53083367 |
| 121 | TTK | 0.52849651 |
| 122 | PRKG2 | 0.51497181 |
| 123 | MUSK | 0.50822514 |
| 124 | CAMK2D | 0.50170671 |
| 125 | EPHA3 | 0.49369778 |
| 126 | TAOK1 | 0.49280172 |
| 127 | CHEK2 | 0.48975120 |
| 128 | CSNK1A1L | 0.48834062 |
| 129 | BMPR2 | 0.48435123 |
| 130 | STK11 | 0.48260400 |
| 131 | MINK1 | 0.47055480 |
| 132 | MAP3K7 | 0.46863681 |
| 133 | ATM | 0.45171660 |
| 134 | PAK3 | 0.43545657 |
| 135 | NEK6 | 0.43508038 |
| 136 | CHEK1 | 0.43441644 |
| 137 | RET | 0.43388131 |
| 138 | CSNK1E | 0.43185905 |
| 139 | RPS6KA4 | 0.42642507 |
| 140 | GRK6 | 0.42480967 |
| 141 | PRKACA | 0.42026649 |
| 142 | KIT | 0.41076931 |
| 143 | FES | 0.40624167 |
| 144 | NEK1 | 0.40208647 |
| 145 | BUB1 | 0.39933703 |
| 146 | CDC42BPA | 0.39654979 |
| 147 | MAP3K12 | 0.39030725 |
| 148 | PKN1 | 0.38568165 |
| 149 | PRKDC | 0.38203788 |
| 150 | EPHA4 | 0.37466558 |
| 151 | PRKCA | 0.37426561 |
| 152 | BRAF | 0.37266667 |
| 153 | ITK | 0.36734573 |
| 154 | PRKACG | 0.34820147 |
| 155 | MAP3K5 | 0.34711599 |
| 156 | CSNK1G2 | 0.33785438 |
| 157 | PRKACB | 0.33783213 |
| 158 | MAP2K2 | 0.33723686 |
| 159 | MAP4K1 | 0.33462900 |
| 160 | CHUK | 0.33396725 |
| 161 | PRKCI | 0.33149426 |
| 162 | PRKG1 | 0.32882573 |
| 163 | PLK4 | 0.32369186 |
| 164 | CSNK1A1 | 0.32175003 |
| 165 | FGFR2 | 0.28815236 |
| 166 | STK38L | 0.28460467 |
| 167 | NME1 | 0.28123797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.31301996 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.89697508 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.73585531 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.47073271 |
| 5 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.35001757 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11199472 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.09430423 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.08116887 |
| 9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.06017057 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 14.4110034 |
| 11 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84743754 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.83470396 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.79963739 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.77728802 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72677520 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.71664327 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70694072 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.58536592 |
| 19 | RNA polymerase_Homo sapiens_hsa03020 | 1.57777430 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53969331 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46073756 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.45402818 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43264028 |
| 24 | Proteasome_Homo sapiens_hsa03050 | 1.43188057 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42348791 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39877182 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.39864625 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.36395729 |
| 29 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34564899 |
| 30 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34339922 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34038196 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.32415564 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.30586558 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.27520068 |
| 35 | Peroxisome_Homo sapiens_hsa04146 | 1.25167953 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 1.23862466 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.22887684 |
| 38 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19304892 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17058309 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16557972 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.11066854 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.07712635 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06434372 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04486031 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.00879332 |
| 46 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.95607334 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95075037 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.93765095 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.92864449 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92256489 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91482720 |
| 52 | Huntingtons disease_Homo sapiens_hsa05016 | 0.90233748 |
| 53 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88728032 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87049126 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 0.86923950 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84976441 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84523578 |
| 58 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.84269182 |
| 59 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82674535 |
| 60 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80620709 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78872836 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77957521 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77257512 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75951684 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73428839 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73030802 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71922866 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70472745 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70065752 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69807598 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67946055 |
| 72 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66367924 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66332064 |
| 74 | Salivary secretion_Homo sapiens_hsa04970 | 0.66289055 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65115453 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64592488 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64469434 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63496000 |
| 79 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.63493866 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62948816 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.62878052 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62186859 |
| 83 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.62181394 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58286010 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55496740 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.54512951 |
| 87 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54276591 |
| 88 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.53373249 |
| 89 | Axon guidance_Homo sapiens_hsa04360 | 0.53162547 |
| 90 | Allograft rejection_Homo sapiens_hsa05330 | 0.52694174 |
| 91 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52061918 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51921928 |
| 93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51906573 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.51246329 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51158865 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50176373 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49517735 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.48945669 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.48267105 |
| 100 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.48086978 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47556344 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47425875 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47145583 |
| 104 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46898821 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46606125 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45772878 |
| 107 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45562121 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45168873 |
| 109 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44464813 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.44376356 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44282536 |
| 112 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42069128 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41382028 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.41051104 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39164250 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38648925 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38290962 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37414521 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37023526 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.36725920 |
| 121 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36160711 |
| 122 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35883610 |
| 123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35486460 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35292450 |
| 125 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.34899200 |
| 126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34487413 |
| 127 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33980156 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33306082 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33108176 |
| 130 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32963678 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32509333 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32187462 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31910535 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31812044 |
| 135 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.31257608 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30972402 |
| 137 | Long-term depression_Homo sapiens_hsa04730 | 0.30413261 |
| 138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.30217051 |
| 139 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30104435 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29590941 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29445080 |
| 142 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29438251 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.28426395 |
| 144 | Taste transduction_Homo sapiens_hsa04742 | 0.28365718 |
| 145 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28356278 |
| 146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27744091 |
| 147 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27029908 |
| 148 | Alcoholism_Homo sapiens_hsa05034 | 0.26476564 |
| 149 | RNA degradation_Homo sapiens_hsa03018 | 0.26103333 |
| 150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26041357 |
| 151 | Purine metabolism_Homo sapiens_hsa00230 | 0.25679331 |
| 152 | Glioma_Homo sapiens_hsa05214 | 0.25587079 |
| 153 | Bile secretion_Homo sapiens_hsa04976 | 0.24526398 |
| 154 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24044312 |
| 155 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23482491 |
| 156 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23246386 |
| 157 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.22468294 |
| 158 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22364913 |
| 159 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21888873 |
| 160 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.21547500 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20436675 |
| 162 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18788330 |
| 163 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18222329 |
| 164 | Melanogenesis_Homo sapiens_hsa04916 | 0.17786897 |
| 165 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17574696 |
| 166 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.15823325 |
| 167 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.15144572 |
| 168 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.15122772 |

